Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.

Cathepsin K is a recently identified lysosomal cysteine proteinase. It is abundant in osteoclasts, where it is believed to play a vital role in the resorption and remodeling of bone. Pycnodysostosis is a rare inherited osteochondrodysplasia that is caused by mutations of the cathepsin-K gene, characterized by osteosclerosis, short stature, and acroosteolysis of the distal phalanges. With a view to delineating the role of cathepsin K in bone resorption, we generated mice with a targeted disruption of this proteinase. Cathepsin-K-deficient mice survive and are fertile, but display an osteopetrotic phenotype with excessive trabeculation of the bone-marrow space. Cathepsin-K-deficient osteoclasts manifested a modified ultrastructural appearance: their resorptive surface was poorly defined with a broad demineralized matrix fringe containing undigested fine collagen fibrils; their ruffled borders lacked crystal-like inclusions, and they were devoid of collagen-fibril-containing cytoplasmic vacuoles. Assaying the resorptive activity of cathepsin-K-deficient osteoclasts in vitro revealed this function to be severely impaired, which supports the contention that cathepsin K is of major importance in bone remodeling.

[1]  A. Hollander,et al.  Molecular Interaction and Matrix Assembly , 1998, The Biochemical journal.

[2]  K. Kanaoka,et al.  Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. , 1998, Journal of biochemistry.

[3]  J G Gleason,et al.  Design of potent and selective human cathepsin K inhibitors that span the active site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Kumegawa,et al.  Cathepsin K Antisense Oligodeoxynucleotide Inhibits Osteoclastic Bone Resorption* , 1997, The Journal of Biological Chemistry.

[5]  B. Gelb,et al.  Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency , 1996, Science.

[6]  C. Debouck,et al.  Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts (*) , 1996, The Journal of Biological Chemistry.

[7]  D. Mcnulty,et al.  Proteolytic Activity of Human Osteoclast Cathepsin K , 1996, The Journal of Biological Chemistry.

[8]  S. J. Jones,et al.  Scanning electron microscopy of bone: Instrument, specimen, and issues , 1996, Microscopy research and technique.

[9]  M. Cecchini,et al.  Recent developments in the understanding of the pathophysiology of osteopetrosis. , 1996, European journal of endocrinology.

[10]  P. Yelick,et al.  Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  D. Brömme,et al.  Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. , 1995, Biological chemistry Hoppe-Seyler.

[12]  R. Derynck,et al.  Toward a molecular understanding of skeletal development , 1995, Cell.

[13]  G. Bilbe,et al.  Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. , 1995, Biochemical and biophysical research communications.

[14]  S. Weiss,et al.  Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2 , 1995, FEBS letters.

[15]  A. Ferrando,et al.  Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues. , 1994, The Journal of biological chemistry.

[16]  Sheila J. Jones,et al.  Inhibition of bone resrption by selctive inactivators of cysteine proteinases , 1994, Journal of cellular biochemistry.

[17]  C. Peters,et al.  Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. , 1994, American journal of human genetics.

[18]  M. Kumegawa,et al.  Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. , 1994, The Journal of biological chemistry.

[19]  C. Peters,et al.  Targeted disruption of the M(r) 46,000 mannose 6‐phosphate receptor gene in mice results in misrouting of lysosomal proteins. , 1993, The EMBO journal.

[20]  N. Jenkins,et al.  Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein , 1993, Cell.

[21]  T. Yoneda,et al.  Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Wagner,et al.  Bone and haematopoietic defects in mice lacking c-fos , 1992, Nature.

[23]  E. Hunziker,et al.  Preservation of cartilage matrix proteoglycans using cationic dyes chemically related to ruthenium hexaammine trichloride. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  J. Delaissé,et al.  Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases , 1992, Journal of cellular physiology.

[25]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[26]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[27]  E B Hunziker,et al.  Stereology for anisotropic cells: Application to growth cartilage * , 1986, Journal of microscopy.

[28]  J. Delaisse,et al.  In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. , 1984, Biochemical and biophysical research communications.

[29]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.